Evaluating Darbepoetin Treatment Strategies for Managing Anaemia in Haemodialysis Patients: Effects on All-Cause Mortality From a Target Trial Emulation Using Electronic Health Record Data.

Birnie K, Caskey FJ, Ben-Shlomo Y, Nitsch D, Casula A, Murray EJ, Sterne JAC

Open source

DOI
10.1002/pds.70507
Published
2026 Nov
Container
Pharmacoepidemiology and drug safety
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pds.70507,
  title = {Evaluating Darbepoetin Treatment Strategies for Managing Anaemia in Haemodialysis Patients: Effects on All-Cause Mortality From a Target Trial Emulation Using Electronic Health Record Data.},
  author = {Birnie K and Caskey FJ and Ben-Shlomo Y and Nitsch D and Casula A and Murray EJ and Sterne JAC},
  year = {2026},
  journal = {Pharmacoepidemiology and drug safety},
  doi = {10.1002/pds.70507},
  url = {https://doi.org/10.1002/pds.70507}
}

RIS

TY  - JOUR
TI  - Evaluating Darbepoetin Treatment Strategies for Managing Anaemia in Haemodialysis Patients: Effects on All-Cause Mortality From a Target Trial Emulation Using Electronic Health Record Data.
AU  - Birnie K
AU  - Caskey FJ
AU  - Ben-Shlomo Y
AU  - Nitsch D
AU  - Casula A
AU  - Murray EJ
AU  - Sterne JAC
PY  - 2026
JO  - Pharmacoepidemiology and drug safety
DO  - 10.1002/pds.70507
UR  - https://doi.org/10.1002/pds.70507
ER  - 

APA

K, B., FJ, C., Y, B., D, N., A, C., EJ, M., & JAC, S. (2026). Evaluating Darbepoetin Treatment Strategies for Managing Anaemia in Haemodialysis Patients: Effects on All-Cause Mortality From a Target Trial Emulation Using Electronic Health Record Data.. Pharmacoepidemiology and drug safety. https://doi.org/10.1002/pds.70507

Source records